Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus-based Immunosuppression in Liver Transplant for HCC
NCT03500848Phase 3Unknown
- Sponsor
- Southern Medical University
- Start
- May 2018
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in hepatocellular carcinoma (HCC), sponsored by Southern Medical University. Status: unknown.
02
Drugs
sirolimus
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03500848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500848.